| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50079 |
Flow7000 |
human |
prepuce |
Normal diploid fibroblasts with limited life span. |
|
| 2 | general cells |
IFO50278 |
PC-12 |
rat |
adrenal medulla |
pheochromocytoma, neuronal differentiation by NGF, grow in suspension |
|
| 3 | general cells |
IFO50373 |
TKC2 |
mouse |
kidney |
cAMP synthesis is stimulated by arginine vasopressin in the cells. Growth temperature is 33 C. |
|
| 4 | general cells |
IFO50416 |
3T3-L1 |
mouse |
embryo |
3T3 L1 cell line is a substrain of 3T3-Swiss albino cell line. 3T3 L1 cells convert adipose-like cells at confluent. |
|
| 5 | general cells |
JCRB0013 |
16-8 |
mouse |
spleen |
Mouse hybridoma cell line producing monoclonal antibody to human erythrocyte. |
|
| 6 | general cells |
JCRB0014 |
19-7 |
mouse |
spleen |
Mouse hybridoma cell line producing monoclonal antibody to human erythrocyte. |
|
| 7 | general cells |
JCRB0192 |
OCUM-1 |
human |
stomach |
Human gastric cancer cell line from poorly differentiated adenocarcinoma. |
|
| 8 | general cells |
JCRB0208 |
CCK-81 |
human |
colon |
adenocarcinoma |
|
| 9 | general cells |
JCRB1006.2F |
OUMS-36T-2F |
human |
embryo |
fibroblast, immortalized by hTRT, derivative of OUMS-36 |
|
| 10 | general cells |
JCRB1148 |
KMBC-2 |
human |
urinary bladder |
Urinary bladder cancer cell line |
|
| 11 | general cells |
JCRB1221 |
NCC-RbC-92 |
human |
primary retinoblastoma |
Huaman retinoblastoma cell line. The growth is extremely slow. |
|
| 12 | general cells |
JCRB1358.03 |
SRBC-P20-13-13 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
| 13 | general cells |
JCRB1417 |
KYSE960 |
human |
esophagus |
Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 14 | general cells |
JCRB1456 |
KYSE1240 |
human |
esophagus |
Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 15 | general cells |
JCRB1483 |
KYAE-1 |
human |
Pleyral effusion |
Human esophageal adenocarcinoma cell line. |
|
| 16 | genetically-modified cells |
JCRB1517 |
POLK F171A MSH- |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH-, POLK KO/F171A, TK+/+) |
|
| 17 | genetically-modified cells |
JCRB1526 |
POLK KO-CD comp |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POLK KO->stable transfectant of pEF6-Polk D198A/D199A, TK+/-) |
|
| 18 | general cells |
JCRB1548 |
H-1A(H123) |
mouse |
bone marrow |
Mouse bone marrow-derived osteoblast-like cell line. |
|
| 19 | general cells |
JCRB1634 |
VV-B2D10 |
mouse x mouse |
|
Mouse hybridoma producing mAb to hemagglutinine (HA) of vaccinia virus |
|
| 20 | general cells |
JCRB1635 |
ITSM |
human |
ascites |
Human B cell line established from patient diagnosed as pseudomyxoma peritonei. |
|
| 21 | general cells |
JCRB1783 |
BALM-6 |
human |
bone marrow |
B cell leukemia cell line |
|
| 22 | general cells |
JCRB9091 |
Y3-Ag 1.2.3 |
rat |
myeloma |
myeloma, kappa secreting, 8-azaguanine resistant, (Lou rat) |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.